Business
Change of Venue for General Meeting-17 Feb 2020
Change of Venue for General Meeting-17 Feb 2020.
About this update from Valirx Plc
[{"type":"text","content":"\n \nRNS Number : 6842C ValiRx PLC 12 February 2020 \n\n \n \n \n \nValiRx Plc\n(\"ValiRx\" or the \"Company\")\n \nCHANGE OF VENUE FOR GENERAL MEETING - 17 FEBRUARY 2020\n \nLondon, UK, 12 February 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces that due to flooding at the venue proposed for the General Meeting convened for 9:00 a.m. on 17 February 2020, the Company has changed the location of the General Meeting from 180-186 Kings Cross Road, London, WC1X 9DE (\"Original Venue\") to the offices of Allenby Capital Limited, 5 St. Helen's Place, London, EC3A 6AB (\"New Venue\").\n \nThe General Meeting will commence at 9:00 a.m. on 17 February 2020 at the Original Venue for the sole purpose of immediately adjourning it to 9:45 a.m. at the New Venue.\n \nShareholders should therefore make their way directly to the New Venue for 9:45 a.m. on 17 February 2020 at which time the business of the General Meeting will be conducted. Any shareholders who arrive at the Original Venue at 9:00 a.m. will be invited to go to the New Venue.\n \nThe business to be conducted at the General Meeting remains as set out in the Notice of General Meeting and no other changes to the procedures for voting at and attending the General Meeting are proposed. There will be no effect on voting instructions already given by way of proxy card or through or other intermediaries, which will remain valid.\n \n \nFor more information, please contact:\n \n\n\n\n\nValiRx plc\n\n\nTel: +44 (0) 20 3008 4416\nwww.valirx.com\n\n\n\n\nDr Satu Vainikka, Chief Executive\n\n\nTel: +44 (0) 20 3008 4416\n\n\n\n\nTarquin Edwards, Head of Communications.\n\n\nTel: +44 (0) 7879 458 364\[email protected]\n\n\n\n\n \n\n\n \n\n\n\n\nCairn Financial Advisers LLP (Nominated Adviser) \nLiam Murray / Jo Turner / Ludovico Lazzaretti\n\n\nTel: +44 (0) 20 7213 0880\n\n\n\n\n \n\n\n \n\n\n\n\nAllenby Capital Limited (Joint Broker)\nJeremy Porter / Alex Brearley (Corporate Finance)\nKelly Gardiner (Equity Sales)\n\n\nTel: +44 (0) 20 3328 5656\n \n\n\n\n\n \n\n\n \n\n\n\n\nETX Capital Limited (Joint Broker)\nThomas Smith\n\n\nTel: +44 (0) 20 7392 1568\n \n\n\n\n\n \n\n\n \n\n\n\n\n \n \nNotes for Editors\nAbout ValiRx...